- Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B) Hepatocellular Carcinoma Patients
-
Zhaohui Z, Shunli S, Bin C, Shaoqiang , Yunpeng H, Ming K, Lijian L, Gang PB
- KMID: 2437599
- Cancer Res Treat.
- 2019 Jan;51(1):65-72.
- doi: 10.4143/crt.2018.038
PURPOSE: The intermediate stage of hepatocellular carcinoma (HCC) (Barcelona Clinic Liver Cancer [BCLC] B) comprises a highly heterogeneous population, and the treatment strategy is still controversial. Because of the heterogeneity,... -
- CITED
-
- Close
- SHARE
-
- Close
